This inventor holds 1 USPTO granted patent, plus 4 CIPO patents and 1 EPO patent. Top assignee: Gilead Apollo, LLC. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Sijun Hu: Innovator in ACC Inhibition
Introduction
Sijun Hu is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of pharmaceutical sciences. His work primarily focuses on developing innovative compounds that target specific biological pathways.
Latest Patents
Sijun Hu holds a patent for "Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof." This invention provides solid forms of compounds that are useful as inhibitors of Acetyl CoA Carboxylase (ACC). The patent outlines compositions, methods of production, and applications for treating ACC-mediated diseases.
Career Highlights
Sijun Hu is currently associated with Gilead Apollo, LLC, where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest to find effective treatments for diseases linked to ACC.
Collaborations
Sijun has collaborated with esteemed colleagues, including John C Amedio, Jr. and Henry Morrison, to further enhance the impact of his research.
Conclusion
Sijun Hu's innovative work in ACC inhibition exemplifies the critical role of inventors in advancing medical science. His contributions are paving the way for new therapeutic options in the treatment of ACC-mediated diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile